F. Shi

The ARGO-YBJ Collaboration

T. D. Girolamo, J. Liu, R. Santonico, 2019 .

Heterologous CoronaVac plus Ad5-nCOV versus homologous CoronaVac vaccination among elderly: a phase 4, non-inferiority, randomized study

L. Hou, H. Pan, W. Chen, 2022, medRxiv.

Note from the editors: The 2012 impact factors.

A. N. Robertson, M. Mielke, Y. Zhou, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

Wei Chen, W. Chen, J. Liu, 2022, The Lancet Respiratory Medicine.